Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Health, Fitness & Food

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)

Products You May Like

Articles You May Like

Spinach Feta Frittata
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
Free 7 Day Healthy Meal Plan (March 3-9)
Running Is Inherently Political — and It’s About Time TikTok Has the Conversation
What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can

Leave a Reply

Your email address will not be published. Required fields are marked *